|
2017
|
Invention
|
Methods for ameliorating infusion reactions. Certain embodiments of the invention provide methods... |
|
2016
|
Invention
|
Treating hepatitis b virus infection using crispr. The present invention provides compositions co... |
|
|
Invention
|
Delivering crispr therapeutics with lipid nanoparticles. The present invention provides lipid par... |
|
|
Invention
|
Novel lipid formulations for nucleic acid delivery.
The present invention provides novel, stable... |
|
|
Invention
|
Compositions and methods for silencing expression of hepatitis d virus rna. The present invention... |
|
|
Invention
|
Compositions and methods for delivering messenger rna.
The present invention provides compositio... |
|
|
Invention
|
Compositions and methods for treating hypertriglyceridemia. The present invention provides compos... |
|
2015
|
Invention
|
Compositions and methods for silencing ebola virus expression. The present invention provides com... |
|
|
Invention
|
Compositions and methods for silencing ebola virus gene expression.
The present invention provid... |
|
|
Invention
|
Compositions and methods for silencing hepatitis b virus gene expression. The present invention p... |
|
|
Invention
|
Compositions and methods for silencing marburg virus gene expression. The present invention provi... |
|
|
Invention
|
Compositions and methods for silencing apolipoprotein c-iii expression. The present invention pro... |
|
|
Invention
|
Silencing of polo-like kinase expression using interfering rna.
The present invention provides c... |
|
2014
|
Invention
|
Compositions and methods for delivering messenger rna. The present invention provides composition... |
|
|
Invention
|
Compositions and methods for silencing ebola virus gene expression. The present invention provide... |
|
2013
|
Invention
|
Cationic lipids and methods for the delivery of therapeutic agents. The present invention provide... |
|
|
Invention
|
Novel trialkyl cationic lipids and methods of use thereof.
The present invention provides compos... |
|
|
Invention
|
Trialkyl cationic lipids and methods of use thereof. The present invention provides compositions ... |
|
|
Invention
|
Nicked polynucleotide complexes for multivalent rna interference. The present invention includes ... |
|
2012
|
Invention
|
Compositions and methods for silencing smad4. The present invention provides compositions compris... |
|
|
Invention
|
Compositions and methods for silencing aldehyde dehydrogenase. The present invention provides com... |
|
|
Invention
|
Cationic lipids and methods of use thereof. The present invention provides compositions and metho... |
|
|
Invention
|
Novel lipid formulations for delivery of therapeutic agents to solid tumors.
The present inventi... |
|
|
Invention
|
Silencing of csn5 gene expression using interfering rna.
The present invention provides composit... |
|
2011
|
Invention
|
Non-liposomal systems for nucleic acid delivery. The present invention provides novel, stable lip... |
|
|
Invention
|
Lipid encapsulated interfering rna.
The present invention provides compositions and methods for ... |
|
|
Invention
|
Novel cationic lipids and methods of use thereof.
The present invention provides compositions an... |
|
|
Invention
|
Compositions and methods for silencing apolipoprotein b. The present invention provides compositi... |
|
|
Invention
|
Novel cyclic cationic lipids and methods of use. The present invention provides compositions and ... |
|
|
Invention
|
Novel cationic lipids and methods of use thereof. The present invention provides compositions and... |
|
|
Invention
|
Modified sirna molecules and uses thereof.
The present invention provides chemically modified si... |
|
|
Invention
|
Snalp formulations containing polyoxazoline-dialkyloxypropyl conjugates.
The present invention p... |
|
2010
|
Invention
|
Snalp formulations containing antioxidants.
The present invention provides methods of preventing... |
|
|
Invention
|
Snalp formulations containing antioxidants. The present invention provides methods of preventing,... |
|
|
Invention
|
Compositions and methods for silencing genes expressed in cancer. The present invention provides ... |
|
|
Invention
|
Sirna silencing of filovirus gene expression.
The present invention provides siRNA molecules tha... |
|
|
Invention
|
Improved cationic lipids and methods for the delivery of therapeutic agents. The present inventio... |
|
|
Invention
|
Lipid encapsulated dicer-substrate interfering rna.
The present invention provides novel, stable... |
|
|
Invention
|
Sirna silencing of apolipoprotein b.
The present invention provides nucleic acid-lipid particles... |
